219923-93-0 Usage
Uses
Used in Pharmaceutical Research and Development:
Urea, [4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-, is used as a research compound for exploring its potential pharmacological activities. The presence of the piperazine ring suggests it may have applications in the development of drugs with antipsychotic, antiemetic, and anthelmintic properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Urea, [4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-, is used as a lead compound for the design and synthesis of new drugs. Its structural features may offer unique opportunities for the creation of novel therapeutic agents with improved efficacy and selectivity.
Used in Drug Discovery:
Urea, [4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-, is utilized in drug discovery processes to identify new molecular entities with potential therapeutic benefits. Its chemical structure may provide insights into the development of drugs targeting various diseases and conditions.
Note: The specific applications and industries for Urea, [4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-, are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the general properties and potential of piperazine-containing compounds in pharmaceutical research and development. Further studies would be necessary to confirm these applications and identify additional uses in specific industries.
Check Digit Verification of cas no
The CAS Registry Mumber 219923-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,9,2 and 3 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 219923-93:
(8*2)+(7*1)+(6*9)+(5*9)+(4*2)+(3*3)+(2*9)+(1*3)=160
160 % 10 = 0
So 219923-93-0 is a valid CAS Registry Number.
219923-93-0Relevant academic research and scientific papers
Meerpoel, Lieven,Backx, Leo J. J.,Van Der Veken, Louis J. E.,Heeres, Jan,Corens, David,De Grout, Alex,Odds, Frank C.,Van Gerven, Frans,Woestenborghs, Filip A. A.,Van Breda, Andre,Oris, Michel,Van Dorsselaer, Pascal,Willemsens, Gustaaf H. M.,Vermuyten, Karen J. P.,Marichal, Patrick J. M. G.,Vanden Bossche, Hugo F.,Ausma, Jannie,Borgers, Marcel
, p. 2184 - 2193 (2005)
In search for new compounds with potential for clinical use as antifungal agents in dermatology, a series of 12 azole compounds were synthesized stereospecifically and investigated specifically for their activity against dermatophyte fungal infections in